OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON THE DEVELOPMENT OF PRODUCTS FOR SPECIFC IMMUNOTHERAY FOR THE TREATMENT OF ALLERGIC DISEASE